Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.45 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.40 |
| ▸ | CDC25A | P30304 | 4/20 | 0.40 |
| ▸ | CDC25B | P30305 | 4/20 | 0.40 |
| ▸ | BCHE | P06276 | 3/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15588772 | 1.00 | HSD11B1 (0.45) | HSD11B1HSD11B2LMNACYP3A4SMN1; SMN2 | |
| SCHEMBL16502918 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL16982582 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL3973400 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL16984766 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL3967644 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL16984745 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL20086741 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL18197939 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 | |
| SCHEMBL29799288 | 0.82 | ALDH1A1 (0.48) | CYP3A4PTPN1NR1H4ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090232913-A1 | Composition for the Control of Cholesterol Levels | VANADIS BIOSCIENCE LTD. (NZ) | 2009-09-17 | — | — | US | claimed |
| US-20090074895-A1 | COMPOSITION AND USES THEREOF | VANADIS BIOSCIENCE LTD (NZ) | 2009-03-19 | — | — | US | claimed |
| WO-2006116814-A1 | COMPOSITION AND USES THEREOF | VANADIS BIOSCIENCE LTD (NZ) | 2006-11-09 | — | — | WO | claimed |
| WO-2006116815-A1 | COMPOSITION FOR THE CONTROL OF CHOLESTEROL LEVELS | VANADIS BIOSCIENCE LTD (NZ) | 2006-11-09 | — | — | WO | claimed |
| EP-3714699-B1 | STEVIA EXTRACT CONTAINING SELECTED STEVIOL GLYCOSIDES AS FLAVOR, SALTY AND SWEETNESS PROFILE MODIFIER | PURECIRCLE USA INC (US) | 2024-12-18 | — | — | EP | disclosed |
| US-12011017-B2 | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier | PURECIRCLE USA INC. (US) | 2024-06-18 | — | — | US | disclosed |
| US-11957756-B2 | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier | PURECIRCLE SDN BHD (MY) | 2024-04-16 | — | — | US | disclosed |
| EP-3272232-B1 | REBAUDIOSIDE A AND STEVIOLBIOSIDE COMPOSITIONS | SWEET GREEN FIELDS INTERNATIONAL CO LTD (HK) | 2024-01-03 | — | — | EP | disclosed |
| EP-3003058-B2 | STEVIA EXTRACT CONTAINING SELECTED STEVIOL GLYCOSIDES AS FLAVOR, SALTY AND SWEETNESS PROFILE MODIFIER | PURECIRCLE USA INC (US) | 2023-06-28 | — | — | EP | disclosed |
| US-11202462-B2 | Rebaudioside A and stevioside compositions | SWEET GREEN FIELDS INTERNATIONAL CO., LIMITED (HK) | 2021-12-21 | — | — | US | disclosed |
| US-20210186070-A1 | STEVIA EXTRACT CONTAINING SELECTED STEVIOL GLYCOSIDES AS FLAVOR, SALTY AND SWEETNESS PROFILE MODIFIER | PURECIRCLE USA INC. | 2021-06-24 | — | — | US | disclosed |
| US-10952458-B2 | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier | PURECIRCLE USA INC (US) | 2021-03-23 | — | — | US | disclosed |
| US-20120058247-A1 | REBAUDIOSIDE A AND STEVIOSIDE COMPOSITIONS | Zhejiang Green World Bio-Tech Engineering Co., Ltd . (CN) | 2012-03-08 | — | — | US | disclosed |
| WO-2012025828-A2 | SUPERFINE POWDERED STEVIA | E.P.C. (BEIJING) PLANT PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) | 2012-03-01 | — | — | WO | disclosed |
| CN-102318484-A | Mechanical field sowing method for stevia rebaudiana | ALAER CITY XINTANG HIGH TECH CO LTD | 2012-01-18 | — | — | CN | disclosed |
| US-20100112101-A1 | BIO-AVAILABILITY/BIO-EFFICACY ENHANCING ACTIVITY OF STEVIA REBAUDIANA AND EXTRACTS AND FRACTIONS AND COMPOUNDS THEREOF | LAILA IMPEX (IN) | 2010-05-06 | — | — | US | disclosed |
| US-20090232913-A1 | Composition for the Control of Cholesterol Levels | VANADIS BIOSCIENCE LTD. (NZ) | 2009-09-17 | — | — | US | disclosed |
| US-20090074895-A1 | COMPOSITION AND USES THEREOF | VANADIS BIOSCIENCE LTD (NZ) | 2009-03-19 | — | — | US | disclosed |
| WO-2006116814-A1 | COMPOSITION AND USES THEREOF | VANADIS BIOSCIENCE LTD (NZ) | 2006-11-09 | — | — | WO | disclosed |
| WO-2006116815-A1 | COMPOSITION FOR THE CONTROL OF CHOLESTEROL LEVELS | VANADIS BIOSCIENCE LTD (NZ) | 2006-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090232913-A1 | Composition for the Control of Cholesterol Levels | CETP, HMGCR, CYP46A1 | HSD11B1 46/4885HSD11B2 53/4885LMNA 2634/4885 |
| US-20090074895-A1 | COMPOSITION AND USES THEREOF | SLC5A2, SLC5A1, SLC10A1 | HSD11B1 73/4885HSD11B2 57/4885LMNA 4462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.